Showing results (171-180 of 223) with videos related to
Sort By:
Pageof 23
Cancer Immunology Research|May 20, 2016
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune ResponsivenessLance D Miller, Jeff A Chou, Michael A Black, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2012
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancerSylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.Journal of Translational Medicine|May 10, 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021Paolo A Ascierto, Allison Betof Warner, Christian Blank, et al.Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.Cancers|June 26, 2026
Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical TrialMelanie Spears, Michael Lock, Brian Yaremko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast CancerSilvia C Formenti, Percy Lee, Sylvia Adams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.Nature Medicine|November 7, 2018
Radiotherapy induces responses of lung cancer to CTLA-4 blockadeSilvia C Formenti, Nils-Petter Rudqvist, Encouse Golden, et al.Clinical and Experimental Pharmacology & Physiology|June 20, 2020
SuPAR, a potential inflammatory mediator in psoriasis pathogenesisLamiaa Hamie, Edward Eid, Ossama Abbas, et al.Pageof 23